We're looking for individuals who are currently prescribed or in process to start a GLP-1 medication to take part in our research study.
If you qualify, we will ask you to participate in a 60-minute in-person session held at our research facility in Downtown Chicago. The sessions are being scheduled for October 28th-30th.
The researcher may follow up via message, email, or phone to confirm if you're a fit for the study. Be sure to answer!